The invention relates to recombinant DNA constructs, a method for producing a
recombinant biologically active protein in vivo in the urine of a non-human mammal
using a kidney-specific promoter, such as the uromodulin promoter, and the transgenic
non-human mammals that serve as urine-based bioreactors for protein production.